Stock Market News for March 30, 2026
610 news published.
Tech & AI deals, infrastructure and market trends
Palantir Technologies (PLTR) renewed and expanded its partnership with Stellantis for another five years, reinforcing recurring revenue expectations from connected‑vehicle software.
Digital Realty (DLR) closed its $3.25 billion U.S. hyperscale fund, underscoring institutional appetite for data‑center real assets.
Soluna (SLNH) reported record 2025 growth — pipeline at 4.3GW, a $142 million capital raise and new AI infrastructure initiatives (read), pointing to demand for flexible, GPU‑ready capacity.
Finster AI (FDS) struck a strategic partnership with FactSet to power its new AI‑native banking platform, linking specialized model providers with mainstream financial data distribution.
CXApp Inc. (CXAI) reported FY 2025 results and unveiled a 2026 outlook centered on an agentic AI platform (details), highlighting how workplace automation vendors position AI as a growth lever.
Spire Global (SPIR) successfully launched ten satellites on SpaceX’s Transporter‑16 mission, expanding its Earth‑observation and data services footprint — a tangible capacity and revenue‑growth catalyst for space‑enabled analytics investors should watch.
M&A and strategic sales shaping corporate balance sheets
Sysco (SYY) agreed to acquire Jetro Restaurant Depot to expand into the higher‑margin cash‑and‑carry channel (announcement), a deal that could lift margins and diversify customers.
Leidos (LDOS) closed its $2.4 billion acquisition of ENTRUST, consolidating defense and identity‑services revenue (release).
Uber (UBER) will acquire chauffeur leader Blacklane, expanding premium mobility and potential margin mix (details).
REPAY (RPAY) agreed to acquire KUBRA (terms), a strategic move that broadens REPAY’s payments and customer‑engagement offerings and may accelerate cross‑sell opportunities across enterprise clients.
Funds, private capital and real‑assets moves
Blackstone (BX) announced final close of a record $6.3 billion life sciences fund — the largest private vehicle dedicated to the sector — signaling persistent institutional demand for specialized allocations (details).
Digital Realty’s (DLR) hyperscale fund close and other large capital raises are reshaping allocations toward data‑center real estate as yield seekers chase growth‑linked assets.
Biotech & pharma: approvals, NDAs and pivotal regulatory moves
Praxis Precision Medicines (PRAX) announced FDA acceptance and priority review of its NDA for relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies — a clear binary catalyst for investors watching rare‑disease approvals (read).
BridgeBio (BBIO) filed an NDA for BBP‑418 in LGMD2I/R9 and reported long‑term acoramidis data that reduced all‑cause and cardiovascular mortality through month 54 — moves that could reshape long‑term market expectations for ATTR therapies (NDA, data).
PepGen (PEPG) released topline data from the lowest‑dose MAD cohort in the Phase 2 FREEDOM2 study showing favorable safety, splicing and vHOT signals, an early efficacy read that can de‑risk dose selection (details).
Fortress Biotech (FBIO)'s subsidiary Cyprium Therapeutics closed the sale of a rare pediatric disease priority review voucher for $205 million, a one‑time cash event that materially strengthens the parent’s balance sheet (announcement).
Curanex (CURX) provided a business update tied to its 2025 annual report as Phyto‑N advances toward a planned IND submission (read), a development investors will watch for timeline clarity around first‑in‑human studies.
Medtech and regulatory milestones
Haemonetics (HAE) received FDA approval for expanded labeling of the VASCADE MVP® XL venous vascular closure system (read), a commercial lift that can broaden procedure indications and revenue prospects in vascular access markets.
Abbott (ABT) expanded access to its Precision Oncology portfolio through integration with Flatiron’s OncoEMR®, a commercial step that can accelerate uptake and real‑world evidence capture (read).
Edwards Lifesciences (EW) reported two‑year data on its EVOQUE system that continue to demonstrate sustained patient benefits, supporting adoption and durable structural‑heart revenue potential.
Industrial, defense and hardware highlights
Velo3D (VELO) won a $9.8 million multi‑year Department of War contract supporting the Defense Logistics Agency, reinforcing aerospace and defense revenue visibility for additive‑manufacturing suppliers (details).
HII (HII) is partnering with GrayMatter Robotics to apply physical AI to shipbuilding, a step that may lift productivity and cost control across large naval programs (details).
Mueller Industries (MLI) announced the acquisition of Bison Metals Technologies, a bolt‑on that expands its product mix and fabrication capabilities — notable for industrials investors tracking margin levers and supply‑chain integration.
Crypto, DeFi and frontier finance
Bitmine Immersion Technologies (BMNR) reported 4.732 million ETH and total crypto plus cash holdings of $10.7 billion (announcement), inviting scrutiny around custody and valuation as investors weigh crypto exposure on balance sheets.
DeFi Development Corp. (DFDV) disclosed +442% revenue growth for FY 2025 (read), an outsized expansion that highlights how niche blockchain services can scale quickly — but also raises questions on sustainability and margin quality.
BTQ Technologies (BTQ) provided a full‑year 2025 corporate update highlighting commercial progress across QCIM, QPerfect, QSSN and Bitcoin Quantum (details), notable for investors tracking quantum‑related product commercialization and crypto‑exposure via hardware and services.
Corporate financing, placements and guidance moves
M&T Bank (MTB) announced a new common stock repurchase program (details), a shareholder‑friendly step that can be read as confidence in capital generation and dividend support.
Pilgrim’s Pride (PPC) launched a cash tender offer for up to $250 million of its 6.250% senior notes due 2033, reshaping long‑dated debt risk.
Vertical Aerospace (EVTL) assembled a comprehensive financing package of up to $850 million, easing near‑term funding pressure for the eVTOL developer and extending runway toward commercialization (announcement).
AFC (AFCG) expanded a revolving credit facility with a $30 million additional commitment from an existing FDIC‑insured banking partner (read), a pragmatic liquidity boost that reduces short‑term funding risk for the consumer finance firm.
Boston Omaha (BOC) announced full‑year 2025 financial results (release), numbers investors will parse for underwriting trends across its insurance and railroad holdings as the company balances growth and capital deployment.
Energy, mining and commodities
Gevo (GEVO) announced plans for a major ethanol expansion at its Richardton, North Dakota facility — a volume and feedstock play that could affect biofuel margins and regional supply dynamics (details).
Vox Royalty (VOXR) reported record 2025 results (read), a reminder that royalty models can deliver resilient cash flow when commodity cycles firm up.
Medtech, retail and quarterly result beats
Lulus (LVLU) reported fourth quarter and fiscal 2025 results (release), a retail earnings snapshot investors will parse for margin trends and inventory management in a competitive apparel market.
Biotech earnings and corporate updates
DiaMedica Therapeutics (DMAC) reported full‑year 2025 financial results and provided business highlights (details), items that help reset investor expectations on capital runway and clinical priorities.
Ensysce Biosciences (ENSC) released fourth quarter and full‑year 2025 financials (read), a routine update that keeps funding and partner timelines in focus.
VerifyMe (VRME) reported fourth quarter 2025 financial results (details), a corporate reporting item investors will review for recurring revenue traction in authentication services.
Other notable corporate updates
- Pineapple Financial (PAPL) received an audit opinion with a going concern explanation, a governance and liquidity red flag investors will monitor closely (read).
- Jasper Therapeutics (JSPR) reported fourth quarter and year‑end 2025 financials and provided a corporate update, keeping its transplant‑focused pipeline and cash runway in focus (details).
- Skillsoft (SKIL) received a continued listing standard notice from the NYSE (notice), a compliance flag that could affect investor confidence and share liquidity until resolved.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement